Home > Insider Trading > Filing (0001019687-13-000365)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1140098	Advanced Cell Technology Inc.	ACTC	Pharmaceutical Preparations (2834)	870656515

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1317093	Robert Lanza	C/O Advanced Cell Technology 33 Locke Drive Marlborough MA 01752	Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2012-12-14	20,000	$0.06	23,937,575	No	4	S	Direct
Common Stock	Disposition	2012-12-14	440,000	$0.06	23,497,575	No	4	S	Direct
Common Stock	Disposition	2012-12-14	40,000	$0.06	23,457,575	No	4	S	Direct
Common Stock	Disposition	2012-12-14	545,490	$0.06	22,912,085	No	4	S	Direct
Common Stock	Disposition	2012-12-14	150,000	$0.06	22,762,085	No	4	S	Direct
Common Stock	Disposition	2012-12-14	100,000	$0.06	22,662,085	No	4	S	Direct
Common Stock	Disposition	2012-12-14	43,000	$0.06	22,619,085	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

On December 18, 2012, the reporting person filed a Form 4 that mistakenly reported an issuance of 1,285,714 shares of the issuer's common stock to the reporting person. This issuance did not in fact occur. Instead, 1,285,714 shares of restricted stock that were originally issued to the reporting person on August 8, 2011 vested, which shares of common stock were reported on a Form 4 filed on August 18, 2011. As of December 14, 2012, the reporting person beneficially owned only 22,619,085 shares of common stock.